Isabelle Rochet

Fusion-negative Rhabdomyosarcoma 3D-organoids as an innovative model to predict resistance to cell death inducers

J. Blay, D. Maucort-Boulch, E. Pasquier, 2022, bioRxiv.

Immune contexture of paediatric cancers.

James Ziai, K. Korski, H. Koeppen, 2022, European journal of cancer.

The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomas

J. Blay, Laura Broutier, C. Picard, 2023, Cell death discovery.

BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas

J. Blay, E. Pasquier, Laura Broutier, 2024, bioRxiv.

Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers

E. Pasquier, Clara Savary, Laura Broutier, 2023, Cell reports. Medicine.